Metformin and Congenital Nephrogenic Diabetes Insipidus
Status:
Terminated
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether metformin can increase urine concentration
(osmolality) and decrease the amount of urine in patients with congenital nephrogenic
diabetes insipidus (NDI).